19 results
TOPCAT - Spironolactone for Heart Failure with Preserved Ejection Fraction

N Engl J Med 2014; 370:1383-1392 https://www.nejm.org/doi/10.1056/NEJMoa1313731

CONCLUSIONS:
//www.nejm.org/doi ... ejection fraction, treatment ... causes, aborted cardiac ... dCHF #Cardiology #EBM ... #VisualAbstract
Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2678035/

Mycophenolate versus Azathioprine as Maintenance Therapy
for Induction Treatment ... //www.nejm.org/doi ... LupusNephritis #VisualAbstract ... #Nephrology #EBM
PARAMEDIC2 Trial Visual Abstract: 
Adrenaline vs. Placebo in out-of-hospital
 - Tommaso Scquizzato
@tscquizzato

https://www.nejm.org/doi/full/10.1056/NEJMoa1806842
 A Randomized Trial of
//www.nejm.org/doi ... Out-of-Hospital Cardiac ... Arrest #EBM ... #VisualAbstract
TTH48 - Targeted Temperature Management for 48 vs 24 Hours and Neurologic Outcome After Out-of-Hospital Cardiac
Out-of-Hospital Cardiac ... 318(4):341-350. doi ... out-of-hospital cardiac ... CriticalCare #ICU #VisualAbstract ... #EBM
SALT-ED Trial - Balanced Crystalloids versus Saline in Noncritically Ill Adults

N Engl J Med 2018; 378:819-828
//www.nejm.org/doi ... hospital-free days between treatment ... crystalloids and treatment ... #AKI #MAKE30 #VisualAbstract ... #EBM
The HYPERION Trial - Targeted Temperature Management for Cardiac Arrest with Nonshockable Rhythm - Visual Abstract

NEJM
Management for Cardiac ... //www.nejm.org/doi ... resuscitated from cardiac ... CardiacArrest #VisualAbstract ... #EBM #Nonshockable
Bystander Efforts and 1-Year Outcomes in Out-of-Hospital Cardiac Arrest

N Engl J Med 2017; 376:1737-1747 https://www.nejm.org/doi/full/10.1056/NEJMoa1601891

Conclusion: Bystander
Out-of-Hospital Cardiac ... //www.nejm.org/doi ... Bystander #CPR #VisualAbstract ... #BLS #EBM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
the Preventive Treatment ... Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... #Migraine #CGRP
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
the Preventive Treatment ... Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... #Migraine #CGRP
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
the Preventive Treatment ... to Trial Group #EBM ... #Neuro #IM #Fremanezumab ... #Migraine #CGRP